329 related articles for article (PubMed ID: 16973887)
1. Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis.
Pulichino AM; Rowland S; Wu T; Clark P; Xu D; Mathieu MC; Riendeau D; Audoly LP
J Pharmacol Exp Ther; 2006 Dec; 319(3):1043-50. PubMed ID: 16973887
[TBL] [Abstract][Full Text] [Related]
2. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
[TBL] [Abstract][Full Text] [Related]
3. ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
Harris RR; Black L; Surapaneni S; Kolasa T; Majest S; Namovic MT; Grayson G; Komater V; Wilcox D; King L; Marsh K; Jarvis MF; Nuss M; Nellans H; Pruesser L; Reinhart GA; Cox B; Jacobson P; Stewart A; Coghlan M; Carter G; Bell RL
J Pharmacol Exp Ther; 2004 Dec; 311(3):904-12. PubMed ID: 15277581
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis.
Honda T; Segi-Nishida E; Miyachi Y; Narumiya S
J Exp Med; 2006 Feb; 203(2):325-35. PubMed ID: 16446378
[TBL] [Abstract][Full Text] [Related]
5. Topical ketanserin attenuates hyperalgesia and inflammation in arthritis in rats.
Hong Y; Ji H; Wei H
Pain; 2006 Sep; 124(1-2):27-33. PubMed ID: 16647209
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor.
Imanishi J; Morita Y; Yoshimi E; Kuroda K; Masunaga T; Yamagami K; Kuno M; Hamachi E; Aoki S; Takahashi F; Nakamura K; Miyata S; Ohkubo Y; Mutoh S
Biochem Pharmacol; 2011 Oct; 82(7):746-54. PubMed ID: 21745460
[TBL] [Abstract][Full Text] [Related]
7. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain.
Stöhr T; Krause E; Selve N
Eur J Pain; 2006 Apr; 10(3):241-9. PubMed ID: 15946870
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.
Gierse J; Nickols M; Leahy K; Warner J; Zhang Y; Cortes-Burgos L; Carter J; Seibert K; Masferrer J
Eur J Pharmacol; 2008 Jun; 588(1):93-8. PubMed ID: 18457826
[TBL] [Abstract][Full Text] [Related]
10. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis.
Torres R; Macdonald L; Croll SD; Reinhardt J; Dore A; Stevens S; Hylton DM; Rudge JS; Liu-Bryan R; Terkeltaub RA; Yancopoulos GD; Murphy AJ
Ann Rheum Dis; 2009 Oct; 68(10):1602-8. PubMed ID: 19528034
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis.
Grosios K; Wood J; Esser R; Raychaudhuri A; Dawson J
Inflamm Res; 2004 Apr; 53(4):133-42. PubMed ID: 15060719
[TBL] [Abstract][Full Text] [Related]
12. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
Futaki N; Harada M; Sugimoto M; Hashimoto Y; Honma Y; Arai I; Nakaike S; Hoshi K
J Pharm Pharmacol; 2009 May; 61(5):607-14. PubMed ID: 19405999
[TBL] [Abstract][Full Text] [Related]
13. Intra-articular administration of tachykinin NK₁ receptor antagonists reduces hyperalgesia and cartilage destruction in the inflammatory joint in rats with adjuvant-induced arthritis.
Uematsu T; Sakai A; Ito H; Suzuki H
Eur J Pharmacol; 2011 Oct; 668(1-2):163-8. PubMed ID: 21749865
[TBL] [Abstract][Full Text] [Related]
14. The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models.
Kang SY; Yoon SY; Roh DH; Jeon MJ; Seo HS; Uh DK; Kwon YB; Kim HW; Han HJ; Lee HJ; Lee JH
J Pharm Pharmacol; 2008 Oct; 60(10):1347-54. PubMed ID: 18812028
[TBL] [Abstract][Full Text] [Related]
15. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.
Marabese I; de Novellis V; Palazzo E; Scafuro MA; Vita D; Rossi F; Maione S
Neuropharmacology; 2007 Feb; 52(2):253-62. PubMed ID: 17113112
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.
Zhang Y; Shaffer A; Portanova J; Seibert K; Isakson PC
J Pharmacol Exp Ther; 1997 Dec; 283(3):1069-75. PubMed ID: 9399978
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.
Komatsu T; Sakurada T
Eur J Pharm Sci; 2012 Dec; 47(5):890-5. PubMed ID: 22985876
[TBL] [Abstract][Full Text] [Related]
18. Mathematical analysis of involvement ratio between central and peripheral COX-2 in rat pain models with two types of COX-2 inhibitors with different distribution, celecoxib and CIAA.
Okumura T; Sakakibara A; Murata Y; Kita Y
Eur J Pharmacol; 2008 Jan; 578(1):97-9. PubMed ID: 17716650
[TBL] [Abstract][Full Text] [Related]
19. Quantitative characterization of a repeated acute joint inflammation model in rats.
Peter-Szabo M; Kekesi G; Nagy E; Sziver E; Benedek G; Horvath G
Clin Exp Pharmacol Physiol; 2007; 34(5-6):520-6. PubMed ID: 17439426
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal CART (55-102) attenuates hyperlagesia and allodynia in a mouse model of neuropathic but not inflammatory pain.
Damaj MI; Zheng J; Martin BR; Kuhar MJ
Peptides; 2006 Aug; 27(8):2019-23. PubMed ID: 16814901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
